Homocysteine, folate, and vitamin B12 levels and vertebral fracture risk in postmenopausal women.

The objective of this study was to examine the influence of homocysteine, vitamin B(12), and folate on the prevalence of asymptomatic osteoporotic vertebral fractures (VFs) using vertebral fracture assessment (VFA) in postmenopausal women. The study cohort consisted of 188 consecutive postmenopausal women (mean age, weight, and body mass index of 57.9 ± 8.5 [41-91]yr, 74.4 ± 13.5 [38-150]kg, and 30.4 ± 5.2 [17.1-50.7]kg/m(2), respectively). Lateral VFA images and scans of the lumbar spine and proximal femur were obtained using a Lunar Prodigy Vision densitometer (GE Healthcare Inc., Waukesha, WI). VFs were defined using a combination of Genant's semiquantitative approach and morphometry. Fifty-eight (30.9%) patients had densitometric osteoporosis. VFs were identified using VFA in 76 (40.4%) patients: 61 women had grade 1 VFs and 15 had grade 2 or 3 VFs. No statistical difference was shown between the 3 groups (absence of VFs, VFs grade 1, and VFs grade 2/3) concerning the biological parameters. Comparison of patients according to quartiles of homocysteine levels showed that women in the highest quartile were older and had a lower bone mineral density (BMD); however, the prevalence of VFs was not statistically different from that of women in the other quartile groups. Stepwise regression analysis showed that homocysteine was not independently associated with the presence of VFs, which was mainly related to the osteoporotic status. Although a weak association was observed between hyperhomocysteinemia and low BMD and a trend to higher prevalence of grade 2/3 VFs was observed, our study did not confirm that homocysteine, vitamin B(12), and folate status are important determinants of prevalent asymptomatic VFs in postmenopausal women.

[1]  H. Genant,et al.  Recognizing and reporting osteoporotic vertebral fractures , 2003, European Spine Journal.

[2]  A. Maghraoui,et al.  Reproducibility of bone mineral density measurements using dual X-ray absorptiometry in daily clinical practice , 2005, Osteoporosis International.

[3]  B. Bagni,et al.  Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. , 2008, Bone.

[4]  D. Bauer,et al.  Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond. , 2009, The American journal of medicine.

[5]  S. Vollset,et al.  Plasma Homocysteine, Folate, and Vitamin B12 and the Risk of Hip Fracture: The Hordaland Homocysteine Study , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  W. Herrmann,et al.  The role of hyperhomocysteinemia as well as folate, vitamin B6 and B12 deficiencies in osteoporosis – a systematic review , 2007, Clinical chemistry and laboratory medicine.

[7]  C. Roux,et al.  DXA scanning in clinical practice. , 2008, QJM : monthly journal of the Association of Physicians.

[8]  C. Korninger,et al.  Bone matrix quality and plasma homocysteine levels. , 2009, Bone.

[9]  J. Beilby,et al.  The effects of homocysteine and MTHFR genotype on hip bone loss and fracture risk in elderly women , 2009, Osteoporosis International.

[10]  J. Cauley,et al.  Hip fracture in women without osteoporosis. , 2005, The Journal of clinical endocrinology and metabolism.

[11]  S. Cummings,et al.  Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis , 1996 .

[12]  A. El Maghraoui,et al.  Vertebral fracture assessment in Moroccan women: prevalence and risk factors. , 2009, Maturitas.

[13]  K. Oumghar,et al.  Relation of plasma total homocysteine, folate and vitamin B12 levels to bone mineral density in Moroccan healthy postmenopausal women , 2010, Rheumatology International.

[14]  N. Binkley,et al.  An evaluation of densitometric vertebral fracture assessment in men , 2007, Osteoporosis International.

[15]  A. Zallone,et al.  Accumulation of homocysteine by decreasing concentrations of folate, vitamin B12 and B6 does not influence the activity of human osteoblasts in vitro. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[16]  A. Hofman,et al.  Homocysteine levels and the risk of osteoporotic fracture. , 2004, The New England journal of medicine.

[17]  A. LaCroix,et al.  Homocysteine levels and risk of hip fracture in postmenopausal women. , 2009, The Journal of clinical endocrinology and metabolism.

[18]  A. Zallone,et al.  Increased osteoclast activity in the presence of increased homocysteine concentrations. , 2005, Clinical chemistry.

[19]  J. Iwamoto,et al.  Homocysteine as a predictive factor for hip fracture in stroke patients. , 2005, Bone.

[20]  A Heinonen,et al.  Epidemiology of hip fractures. , 1996, Bone.

[21]  J. Iwamoto,et al.  Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson's disease. , 2005, The American journal of medicine.

[22]  M. Hannan,et al.  B vitamins, homocysteine, and bone disease: Epidemiology and pathophysiology , 2007, Current osteoporosis reports.

[23]  Jacques P. Brown,et al.  Recognizing and reporting vertebral fractures: reducing the risk of future osteoporotic fractures. , 2007, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[24]  P. Delmas,et al.  Homocysteine and fracture risk in postmenopausal women: the OFELY study , 2007, Osteoporosis International.

[25]  A. Grieco.  Homocystinuria: pathogenetic mechanisms. , 1977, The American journal of the medical sciences.

[26]  P. Delmas,et al.  Biochemical Markers of Bone Turnover, Endogenous Hormones and the Risk of Fractures in Postmenopausal Women: The OFELY Study , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  A. El Maghraoui,et al.  Vertebral fracture assessment in healthy men: prevalence and risk factors. , 2008, Bone.

[28]  D. Cucinotta,et al.  Folate, but not homocysteine, predicts the risk of fracture in elderly persons. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[29]  Farzaneh A. Sorond,et al.  The role of homocysteine in multisystem age-related problems: a systematic review. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[30]  A. Maghraoui,et al.  Epidemiology of hip fractures in 2002 in Rabat, Morocco , 2005, Osteoporosis International.

[31]  W. Herrmann,et al.  Homocysteine – a newly recognised risk factor for osteoporosis , 2005, Clinical chemistry and laboratory medicine.

[32]  J. Kanis,et al.  Assessment of fracture risk. , 2009, European journal of radiology.

[33]  A. Dyer,et al.  Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus. , 2008, The Journal of rheumatology.

[34]  D. Kiel,et al.  Plasma B vitamins, homocysteine, and their relation with bone loss and hip fracture in elderly men and women. , 2008, The Journal of clinical endocrinology and metabolism.

[35]  C. Roux,et al.  Reporting of vertebral fractures on spine X-rays , 2005, Osteoporosis International.

[36]  Ali Guermazi,et al.  Identification of vertebral fractures in osteoporosis. , 2002, Seminars in musculoskeletal radiology.

[37]  Shiro Tanaka,et al.  Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment , 2010, Journal of Bone and Mineral Metabolism.